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SALIVA HAS MANY IMPORTANT functions, including the initiation of digestion and the maintenance of oral health. Indeed, severe hyposalivation leads to dental caries, oral pain, and mucosal infections (15) . Salivation is stimulated through the interaction of autonomic neurotransmitters with their respective receptors (i.e., ␣-adrenergic, ␤-adrenergic, and muscarinic-cholinergic) on the surface of acinar cells (5) . Although adrenergic and muscarinic-cholinergic receptors generate the dominant signals that regulate fluid secretion, there is long-standing evidence that saliva formation is also evoked by nonadrenergic, noncholinergic pathways that utilize neuropeptides such as substance P and neuropeptide Y, as well as other molecules released by nerve terminals (25a) . For example, in mouse submandibular gland, ATP induces an increase in the intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) that stimulates fluid secretion through the P2X 7 purinoceptor (29) . Such an increase in [Ca 2ϩ ] i is required by salivary gland acinar cells to activate transepithelial movement of Cl Ϫ , the driving force for fluid production (2, 26) .
The agonist-induced intracellular Ca 2ϩ signal associated with fluid secretion is mainly generated by extracellular Ca 2ϩ influx through cation channels with distinct Ca 2ϩ selectivity. In nonexcitable cells, Ca 2ϩ entry is provided by ion channels that are activated by various chemical and physical stimuli, as well as by depletion of the intracellular Ca 2ϩ store. Some of these Ca 2ϩ entry channels are members of the transient receptor potential (TRP) family. Many TRP channels are orders of magnitude more selective for Ca 2ϩ than for monovalent cations (8) ; thus, Ca 2ϩ influx is considered one of their common physiological properties. Among TRP channels, vanilloid subtype 4 (TRPV4) is gated by a diverse range of stimuli, such as mechanical stimuli, including shear stress and hypotonic cell swelling (19, 20) , endogenous arachidonic acid metabolites (38) , phorbol esters (14, 37) , and moderate heat (39) . TRPV4 is widely expressed throughout the body, including renal (6, 13) and airway (3, 18, 32) epithelia, skin (16) and esophageal (28) keratinocytes, corneal endothelial and epithelial cells (27, 31) , pancreatic beta cells (21, 25, 36) , and salivary glands (9, 22) . Notably, in all these different cell types, the TRPV4 channel has been shown to contribute to the regulation of cytosolic Ca 2ϩ levels. In rat and human submandibular gland cell lines, TRPV4 plays an important role in the osmotic swelling-induced regulatory volume decrease that is dependent on Ca 2ϩ influx (4, 22) . Ca 2ϩ -dependent salivation is the most important function of salivary glands. Although the TRPV4 channel is known to be expressed in salivary glands, its relationship to secretion is unknown. We hypothesized that TRPV4 might modulate the fluid secretion pathway in salivary glands. We found that TRPV4 localized to the basolateral membrane of mouse submandibular gland acinar cells. Activation of this channel with a selective TRPV4 receptor agonist caused Ca 2ϩ influx in isolated acinar cells in a basal-to-apical wave. TRPV4 agonist stimulated fluid secretion and was dependent on an increase in [Ca 2ϩ ] i in isolated submandibular glands. In summary, we report that activation of TRPV4 channels induced salivation in the mouse submandibular gland and, thus, may contribute a novel mechanism to regulate fluid secretion.
MATERIALS AND METHODS
Animals and reagents. C57BL/6J (8 -12 wk old) mice were obtained from Jackson Laboratories (Bar Harbor, ME) and housed in a controlled environment with free access to food and water. All procedures involving the care and use of animals were approved by the National Institute of Dental and Craniofacial Research, National Institutes of Health, Animal Care and Use Committee. HEK-293 cells were obtained from American Type Culture Collection (Manassas, VA). GSK1016790A, RN1734, carbachol (CCh), atropine, and propranolol were purchased from Sigma-Aldrich (St. Louis, MO). A plasmid (TRPV4-pCMV6) encoding a mouse TRPV4 cDNA clone was obtained from OriGene (Rockville, MD). All other chemical reagents were of analytical grade and purchased from Sigma-Aldrich, except where otherwise indicated.
Cell culture and transfection conditions. HEK-293 cells were maintained in medium (DMEM supplemented with 10% fetal bovine serum) containing nonessential amino acids (0.1 mM), sodium pyruvate (1 mM), L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 g/ml) at 37°C in a 5% CO 2 atmosphere humidified incubator. All ingredients were obtained from Invitrogen (Grand Island, NY). To establish cells stably expressing TRPV4, HEK-293 cells were grown in 10-cm petri dishes (ϳ75% confluence) containing 5 g of TRPV4-pCMV6 or empty pcDNA3.1(ϩ) vector with FuGENE 6 transfection reagent (Promega, Madison, WI) in Opti-MEM and serum according to the manufacturer's instructions. After 24 h of transfection, the cells were replated and maintained for 2 wk in growth medium containing 400 g/ml Geneticin (Invitrogen).
Total RNA extraction and RT-PCR. Total RNA extraction and reverse transcription were performed as reported previously (40) . Briefly, total RNA was extracted with TriPure (Roche Applied Science, Indianapolis, IN) according to the manufacturer's instructions. cDNA was prepared from 1 g of total RNA with Moloney murine leukemia virus reverse transcriptase (Thermo Fisher Scientific, Beverly, MA). PCR primers were designed according to the sequence of mouse Trpv4 [NM_022017, aa 1317-1509, 193 bp; 5= GTCTCG-CAAGTTCAAGGACT 3= (forward) and 5= AAACTTACGCCACT-TGTCTC 3= (reverse)] and ␤-actin [NM_007393, aa 779 -1080, 302 bp; 5=-TCCTCCCTGGAGAAGAGCTA-3= (forward) and 5=-TCAG-GAGGAGCAATGATCTTG-3= (reverse)]. The products were separated by electrophoresis on a 1.5% agarose gel, and the DNA bands were visualized by ethidium bromide staining.
Western blotting. Submandibular glands were homogenized with a TissueRuptor (Qiagen, Valencia, CA) in RIPA buffer (SigmaAldrich) containing protease inhibitor cocktail (Thermo Fisher Scientific) at the manufacturer's recommended concentration. Transfected HEK-293 cells were lysed in the same buffer. The homogenate was centrifuged at 1,000 g for 10 min at 4°C, and the protein concentration of the supernatant was measured by the bicinchoninic acid method. Equal amounts of protein (40 g) were separated in a 9% SDSpolyacrylamide gel and transferred to a polyvinylidene difluoride membrane. The membranes were blocked with 5% nonfat milk for 1 h at room temperature, probed with primary antibody directed to the COOH-terminal 50 amino acids of mouse TRPV4 (SAB2104243, Sigma-Aldrich; 1:1,000 dilution) at 4°C overnight, and then incubated with horseradish peroxidase-conjugated secondary antibody (sc2317, Santa Cruz Biotechnology, Santa Cruz, CA; 1:10,000 dilution) at room temperature for 2 h. Immunoreactive bands were visualized with enhanced chemiluminescence (Pierce, Rockford, IL). Blots were stripped and reprobed with an antibody to mouse ␤-actin (ab8227, Abcam, Cambridge, MA; 1:2,500 dilution) as a loading control for standardization of blots.
Immunofluorescence staining. Submandibular glands were dissected from mice and fixed in 4% paraformaldehyde for 5 h at 4°C, dehydrated in 20% sucrose overnight at 4°C, embedded in optimal cutting temperature compound (OCT, Tissue Tek, Elkhart, IN), and stored at Ϫ80°C. HEK-293 cells transfected with pcDNA3.1(ϩ) or TRPV4-pCMV6 were cultured on coverslips and fixed in 4% paraformaldehyde for 10 min at room temperature. Tissue sections (6 m; American Histolabs, Gaithersburg, MD) and HEK-293-containing coverslips were incubated with 10% goat serum for 30 min at room temperature, overnight at 4°C with an antibody to TRPV4 (SAB2104243, Sigma-Aldrich; 1:100 dilution) or antibody to NKCC1 [gift from Dr. Turner (17); 1:2,500 dilution], and then with an Alexa Fluor 488-conjugated (A11008, Invitrogen; 1:1,000 dilution) or Alexa Fluor 594-conjugated (711-587-003, Jackson ImmunoResearch, West Grove, PA; 1:2,000 dilution) secondary antibody for 1 h at 37°C. Nuclei were stained with Hoechst 33342 (H3570, Invitrogen; 1:2,000 dilution). Fluorescence images were captured on a confocal microscope (LSM 710, Carl Zeiss, Wetzlar, Germany). In control sections, rabbit IgG (011-000-002, Jackson ImmunoResearch; 10 g/ml) was used instead of primary antibody.
Ex vivo submandibular gland perfusion. Ex vivo submandibular gland perfusion was performed as previously reported (29) . Briefly, mice were anesthetized with chloral hydrate (400 mg/kg body wt ip). After ligation of all branches of the common carotid artery except the submandibular gland artery, the gland was removed, cannulated, and perfused. The ex vivo perfusion solution contained (in mM) 4.3 KCl, 120 NaCl, 25 NaHCO3, 5 glucose, 10 HEPES, 1 CaCl2, and 1 MgCl2, at pH 7.2. Extracellular Ca 2ϩ -free solutions were made by removing CaCl2. Solutions were maintained at 37°C, gassed with 95% O2-5% CO2, and perfused at 0.8 ml/min using a peristaltic pump. Muscarinic and ␤-adrenergic receptor antagonists were included (0.5 M atropine and 20 M propranolol, respectively) in the perfusate when TRPV4 agonists were used to induce fluid secretion.
Once the gland began to secrete fluid (defined as time 0), stimulation was continued for an additional 5 min. Saliva was collected in precalibrated capillary tubes (VWR, Radnor, PA), and volumes were recorded every 10 s during the first 30 s, at 1 min, and then every 1 min to monitor the flow rate (l/min). Saliva samples were stored at Ϫ80°C until further analysis.
Ca 2ϩ imaging. Submandibular gland acinar cells were prepared by enzyme digestion, as previously reported with minor modification (29) . Briefly, mice were euthanized, and glands were dissected, finely minced, digested in MEM (Invitrogen) containing 1% BSA and 0.125 mg/ml Liberase TL enzyme (Roche Applied Science) for 25 min at 37°C, and then centrifuged. The cell pellet was resuspended and digested in Liberase TL for another 25 min. After digestion, the cells were rinsed in MEM supplemented with 1% BSA.
The fura 2 fluorescence ratiometric method was used to measure [Ca 2ϩ ]i. Cells were loaded with dye by incubation with 2 M fura 2-AM (Invitrogen) for 25 min at room temperature. Imaging was performed using an inverted microscope (IX71, Olympus, Tokyo, Japan) equipped with a Polychrome IV Imaging System coupled to a high-speed digital camera (Till Photonics, Pleasanton, CA). Images from fura 2-loaded cells were acquired every 3 s for GSK1016790A and every 0.5 s for CCh by alternate excitation of light at 340 and 380 nm, and emission was captured at 510 nm using Imaging WorkBench 6.0 software (INDEC BioSystems, Santa Clara, CA). Chamber volume was maintained at ϳ400 l. Cells were perfused with the ex vivo perfusion solution at 37°C. The ratio of fluorescence at 340 nm to fluorescence at 380 nm was calculated, and all data are presented as the change in ratio units. Dose-response experimental points were fitted to a Hill function of the following form:
, where nH is the Hill index, EC50 is the GSK1016790A concentration ([GSK]) required to reach half-maximal activation, and ⌬Fmax and ⌬Fmin correspond to maximal and minimal ⌬fluorescence values, respectively.
Statistics. Values are means Ϯ SE. Tests of statistical significance were performed using Student's t-test or ANOVA followed by a Bonferroni's test for multiple comparisons (Origin 8.0, OriginLab, Northampton, MA). P Ͻ 0.05 was considered statistically significant. All experiments were performed using at least three separate preparations.
RESULTS
Expression and distribution of TRPV4 in mouse submandibular gland. Delany et al. (9) first detected TRPV4 mRNA in salivary glands by dot-blot analysis, but a detailed description of the expression and distribution of TRPV4 in salivary glands is lacking. To confirm that TRPV4 is expressed in salivary gland secretory cells without contribution from nonparenchymal tissue, we isolated mouse submandibular gland acinar cells for PCR analysis. RT-PCR generated products at the expected size for TRPV4 of 193 bp (Fig. 1A) in submandibular gland and submandibular gland acinar cells. Sequence analysis confirmed the identity of the PCR products as TRPV4.
An immunoreactive protein of the expected size, ϳ100 kDa (Fig. 1B) , was detected in TRPV4-transfected HEK-293 cells and submandibular gland tissue with an antibody targeted to amino acids 719 -768 in the COOH terminus of TRPV4. HEK-293 cells transfected with the pcDNA3.1(ϩ) empty vector were used as negative control (Fig. 1B) . Using the same anti-TRPV4 antibody used for Fig. 1B , we also examined the cellular distribution of TRPV4 in transfected HEK-293 cells and mouse submandibular glands by immunofluorescence. We found immunoreactivity in TRPV4-transfected HEK-293 cells (Fig. 1C) , but not in HEK-293 cells transfected with the pcDNA3.1(ϩ) empty vector (insets, Fig.   1C ), confirming that the anti-TRPV4 antibody recognizes TRPV4 protein. In mouse submandibular tissue sections, TRPV4 protein extensively colocalized with NKCC1, an ion cotransporter known to be expressed in the basolateral membrane of salivary gland cells (10) , suggesting that TRPV4 mainly targets to the basolateral membrane of acinar cells (Fig. 1D) . Another TRPV4 antibody (HPA007150, Sigma-Aldrich; 1:100 dilution) targeted to the NH 2 -terminal 98 amino acids (aa 43-140) produced similar results (data not shown).
Activation ] i ( Fig. 2A) that was near maximal (Fig. 2B) . GSK1016790A stimulated an increase in [Ca 2ϩ ] i in a concentration-dependent manner, with an estimated EC 50 of 9.3 nM and a Hill index of 2 (Fig. 2B) .
The TRPV4 channel inhibitor RN1734 was used to test the specificity of GSK101790A on TRPV4 activation. Preincubation with RN1734 significantly attenuated the GSK1016790A-induced elevation of [Ca 2ϩ ] i , consistent with GSK1016790A causing an increase in [Ca 2ϩ ] i through activation of TRPV4 channels (Fig. 2C) . Furthermore, the cytoplasmic Ca 2ϩ response to GSK1016790A was almost completely eliminated in a Ca 2ϩ -free solution (Fig. 2D) ] i . Figure 3A shows a typical example of the development of the cytosolic Ca 2ϩ signal during exposure to 1 M GSK1016790A. The increase in [Ca 2ϩ ] i was initially detected at the basolateral region of the acinar cells and then spread as a wave toward the apical region (Fig. 3C) . The time to half-maximum response was 5.75 Ϯ 2.48 s slower in the apical than basal region (n ϭ 10 cells from 4 experiments). In contrast, the initial rise in [Ca 2ϩ ] i was at the apical pole when the cells were exposed to a muscarinic agonist (0.3 M CCh; Fig.  3B ). Moreover, the Ca 2ϩ signal generated by CCh typically propagated in an apical-to-basal fashion, the opposite direction of the Ca 2ϩ signal generated by GSK1016790A (Fig. 3D) . The average time to half-maximum response for CCh was 1.93 Ϯ 0.67 s slower in the basal than apical region (n ϭ 7 cells from 3 experiments). There were no significant differences between the magnitudes of the [Ca 2ϩ ] i increases in the apical and basolateral regions in the GSK1016790A or CCh groups.
Activation of TRPV4 promoted secretion in submandibular glands. Given that an increase in [Ca 2ϩ ] i plays a central role in stimulating fluid secretion in salivary glands, we predicted that activation of TRPV4 would result in fluid secretion. We tested this hypothesis by perfusing ex vivo submandibular glands with the TRPV4 agonist GSK1016790A. Stimulation with 300 nM GSK1016790A rapidly produced an initial peak secretion in Ͻ1 min followed by a gradual decline to near baseline over the next 2-3 min (Fig. 4A) . At 1 M, GSK1016790A induced a considerably higher initial flow rate during the 1st min, but secretion still returned to baseline within 2-3 min. The response to 5 M GSK1016790A induced a pattern similar to that seen with 1 M GSK1016790A. The total volume of secreted saliva during 5 min of stimulation is shown in Fig. 4B .
To further characterize the specificity of GSK1016790A-induced secretion, the TRPV4 antagonist RN1734 was introduced into the perfusate prior to (1 min) and during GSK1016790A exposure. At 1 M, RN1734 abolished the GSK1016790A-induced secretion, consistent with GSK1016790A acting on the TRPV4 channel (Fig. 4C) . To determine whether TRPV4 activation-induced secretion is a Ca 2ϩ influx-dependent process, submandibular glands were perfused with GSK1016790A in a Ca 2ϩ -free solution. As expected from the results in Fig. 2D , GSK1016790A did not induce fluid secretion in the absence of extracellular Ca 2ϩ (Fig. 4, C and D) .
DISCUSSION
Here we show that TRPV4 channel activation promoted Ca 2ϩ -dependent fluid secretion by mouse submandibular gland acinar cells. Using immunofluorescence, we initially found that TRPV4 was localized mainly to the basolateral membrane of acinar cells. Activation of acinar cells with a TRPV4-selective agonist induced an increase in [Ca 2ϩ ] i . Moreover, consistent with basolateral localization of TRPV4, the increase in [Ca 2ϩ ] i induced by GSK1016790A initiated at the basal pole of acinar cells. Finally, TRPV4 activation stimulated fluid secretion in the intact, ex vivo submandibular gland. These results suggest a previously unacknowledged role for TRPV4 channels in modulating the Ca 2ϩ signal that is critical for stimulating fluid secretion in salivary gland acinar cells. TRPV4 was first found to be expressed in human salivary glands by dot-blot analysis (9) . By isolating mouse submandibular gland acinar cells to eliminate the contribution of message from nonparenchymal tissue, we determined that TRPV4 transcripts are expressed in submandibular gland secretory cells. TRPV4 coimmunolocalized with NKCC1, a basolateral molecular marker (10) , in mouse submandibular gland acinar cells. An earlier study suggested that TRPV4 is also expressed in the apical region (22) . Our study does not preclude this possibility, but it does indicate that TRPV4 is predominantly found in the basolateral membrane in mouse submandibular gland.
GSK1016790A is a novel TRPV4 activator that is more selective and potent than the traditional TRPV4 activator 4␣-phorbol-12,13 didecanoate (34). GSK1016790A induces a Ca 2ϩ increase in several different cell types at nanomolar levels (13, 14, 33) . For example, in TRPV4-transfected HeLa cells, GSK1016790A produces a dose-dependent Ca 2ϩ increase with an EC 50 of 3.3 nM (14) . In isolated mouse submandibular gland acinar cells, we found that GSK1016790A induced a dose-dependent Ca 2ϩ increase, with a calculated EC 50 in the low nanomolar range (9.3 nM), consistent with endogenous expression of TRPV4 channels in this cell type.
An increase in [Ca 2ϩ ] i is an unqualified requirement to stimulate salivation (1 release, in submandibular gland acinar cells. Members of the TRP family of nonselective cation channels have been implicated as Ca 2ϩ influx pathways in salivary glands. For example, the TRP canonical 1 (TRPC1) channel is expressed in the basolateral plasma membrane of mouse submandibular gland acinar cells, where it was found to be a key component of store-operated Ca 2ϩ entry. Indeed, saliva output was significantly reduced by ϳ70% in TRPC1-null mice, demonstrating that TRPC1-mediated Ca 2ϩ influx is critical for salivary fluid secretion (23) . Interestingly, TRPV4 forms heteromeric channels with TRPC1 in vascular endothelial cells and human umbilical vein endothelial cells. In these cell types, thapsigargin-induced Ca 2ϩ entry was markedly reduced by knocking down the expression of TRPC1 or TRPV4 with small interfering RNA. Moreover, expression of TRPC1 in HEK-293 cells caused a much larger thapsigargin-induced inward current if TRPV4 was cotransfected (24) . These results suggest that TRPV4 interaction with TRPC1 may play an important role in Ca 2ϩ entry in some cell types. Whether heteromeric TRPV4-TRPC1 mediates Ca 2ϩ entry in submandibular glands would be an interesting question to address in future studies.
Consistent with our immunolocalization studies, we found that activation of TRPV4 channels generated Ca 2ϩ wave propagation that initiated from the basal region and spread to the apical pole. A similar pattern has been shown for the P2X 4 purinoceptor, a nonselective Ca 2ϩ -permeable cation channel, the expression of which is restricted to the basal region in mouse parotid acinar cells. Selective activation of P2X 4 induces a Ca 2ϩ signal that initiates basally and propagates toward the lumen, independent of the intracellular IP 3 -sensitive Ca 2ϩ store (7) . In contrast, if the receptor channel is restricted to the apical region, the Ca 2ϩ wave direction is expected to be from the apical to the basal, like that seen for the apical P2X 7 channel of parotid acinar cells (7) . Thus the plasma membrane location of Ca 2ϩ -conducting cation receptor channels like P2X 4 ] i induced by muscarinic receptor activation would be expected to occur at the apical pole (site of the major IP 3 -sensitive Ca 2ϩ stores) and to propagate toward the basolateral region, as seen in rat parotid acinar cells (35) and mouse submandibular gland acinar cells (Fig. 3, C and D) .
Notably, GSK1016790A evoked a significant increase in [Ca 2ϩ ] i that induced a transient ex vivo secretion. Although a sustained elevation of [Ca 2ϩ ] i is frequently observed in different types of TRPV4-positive cells (13, 14, 27, 28) , many TRP channels, including TRPV4, partially desensitize in patchclamp experiments (12, 14, 30) . It has been reported that GSK1016790A can cause a rapid downregulation of TRPV4 within 3 min in TRPV4-transfected cells. Downregulation was associated with a ϳ30% decrease of TRPV4 abundance in the plasma membrane that remained depressed throughout GSK1016790A stimulation (14) . In contrast, hypotonic stress did not desensitize TRPV4 in renal collecting duct M-1 cells, which endogenously express TRPV4. In this latter case, TRPV4 plasma membrane levels remained relatively constant over many minutes of hypotonic stress (13) . Since TRPV4 activation of ex vivo salivary gland secretion lasted only 2-3 min, it is not clear why the increase in [Ca 2ϩ ] i induced by GSK1016790A remained elevated in isolated acinar cells. One possibility is that enzymatic digestion of the gland may have altered the interaction of TRPV4 with another membraneassociated regulatory protein. Taken together, this study expands our understanding of the basic physiology of the mouse submandibular gland. We report a novel function for TRPV4 as a basolateral Ca 2ϩ influx pathway in submandibular gland acinar cells, the activation of which stimulates fluid secretion. Moreover, because TRPV4 channel activation bypasses the G protein-coupled receptor response typically associated with salivary gland fluid secretion, further study is warranted to determine the efficacy of TRPV4 channel activators to treat hyposalivation diseases.
